|

Giessen Pulmonary Hypertension in Lung Cancer Registry

RECRUITINGSponsored by University of Giessen
Actively Recruiting
SponsorUniversity of Giessen
Started2020-06-29
Est. completion2026-01-29
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04467333

Summary

The aim of this study is to investigate the frequency and implications of pulmonary hypertension in lung cancer patients. To do so, data will be collected from all lung cancer patients at the university hospital Giessen. All data will be analyzed for possible hints of pulmonary hypertension as a comorbidity in lung cancer patients. All information will be generated from the regular guidelines based course of treatment and there will be no interventions. This study will serve as a prospective register for all lung cancer patients treated at the university hospital Giessen.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patient with lung cancer at the University of Giessen lung Cancer Center.

Exclusion Criteria:

\-

Conditions3

CancerLung CancerPulmonary Hypertension Due to Lung Diseases and Hypoxia

Browse More Trials

Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.